I do not think a single semaglutide study settles anything, but the aggregate is more interesting than any individual paper.
Forum consensus and published consensus diverged here about five years ago and never reconverged.
Baseline first. Without a baseline the after picture is decoration.
The comparison group matters more than the compound when the outcome is something as fuzzy as focus.
What the GLP-1 class does pharmacologically does not require the subjective effect to be large to be real.
Titration is slow by design and rushing it is how people end up miserable.
What is the strongest human evidence anyone here has actually read, not skimmed?
Baseline first.
Stupid question: how do you know whether what is in the vial matches the label at all?
Log dose, time and sleep. Ten seconds a day and it turns the anecdote into something you can look at.
Narrow conclusion.
Nobody has ever been talked out of a stack by a stranger on the internet.